CSR
Loading...
  • Careersarrow_down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Loading...
  • Ελληνικά  EL     English  EN     EN  arrow_down
    • ΕλληνικάEL
    • EnglishEN
  • Global Greece
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
  • Home
  • Companyarrow_down
      < Back
    • Company
    • Company
    • History
    • Fondation Ipsen
  • Sciencearrow_down
      < Back
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
  • Responsibilityarrow_down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patientsarrow_down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Our Storiesarrow_down
      < Back
    • Our Stories
    • Our Stories
    • CSR
    • Our People
    • Patient Centricity
  • Useful Links
  1. Home
  2. Our Stories
  3. CSR

CSR

IPN price

€108.00

 €0.10 (0.09%)

  • Careers
  • Company
  • Responsibility
  • Patients
  • Contact Us
Greece
LinkedIn Twitter Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024

You are now leaving the Ipsen group website.To continue, please click on Continue?